Jenny Shum

Senior Counsel
Norton Rose Fulbright US LLP

New York
United States
T:+1 212 318 3362
New York
United States
T:+1 212 318 3362
Jenny Shum

Jenny Shum



Jenny Shum is a senior counsel in the New York office of Norton Rose Fulbright and is a member of the Intellectual Property practice group. Her practice focuses on patent litigation, including Hatch-Waxman litigation, and international arbitration relating to pharmaceuticals, biomedical devices, and biotechnology. Jenny has experience with a variety of biotechnologies, including antibodies, antivirals, and antibiotics. Jenny also has a technical focus in the autonomous vehicle industry and has published several articles in this space.  In addition to patent validity and infringement matters, she has experience in patent prosecution, due diligence evaluations, freedom-to-operate analyses, trademark prosecution, and client counseling relating to intellectual property. 

Prior to joining Norton Rose Fulbright, Jenny practiced at two major law firms in New York and carried a broad-based intellectual property practice, including contentious disputes, patent prosecution, and intellectual property issues arising in corporate and finance transactions. She also interned at the Boston College Office of Technology Transfer and Licensing, where she concentrated on patent portfolio management.

Before her career in law, Jenny obtained a doctorate in the biological sciences, concentrating on biochemistry and molecular biology.  She has also conducted scientific research domestically, as well as internationally at the Hong Kong University of Science and Technology. She has co-authored several peer-reviewed scientific publications relating to signal transduction mechanisms and the regulation of protein production and has published on the international regulatory requirements and patentability of stem cell research.

She is licensed to practice in New York, including the US District Courts for the Eastern and Southern Districts of New York.

Professional experience

Expand all Collapse all

JD, Boston College Law School, 2010
PhD, Albany Medical College, Biological Sciences, 2003
MS, Albany Medical College, Biological Sciences, 2000
BS, SUNY at Albany, Biochemistry & Molecular Biology and East Asian Studies, 1993

In law school, Jenny served as senior articles editor of the Boston College International & Comparative Law Review.

During graduate school, Jenny was active in student government and served as Vice-President of the Graduate Students Organization.

  • New York State Bar
  • Represented leading U.S. pharmaceutical manufacturer of an abuse-deterrent opioid treatment in reaching a successful conclusion in Hatch-Waxman litigation against a generic competitor.
  • Represented Swedish pharmaceutical manufacturer of a sublingual tablet to treat opioid addiction in a successful patent litigation lawsuit involving a five-day bench trial against a generic manufacturer.
  • Represented large multinational biotechnology company in winning and defending largest known arbitral award in excess of $450 million involving patent infringement and breach of license issues relating to herbicide resistance technology.
  • Represented Japanese pharmaceutical company in a successful ICC arbitration against a major multinational pharmaceutical company regarding contractual and intellectual property disputes.
  • Co-author, "Exploring the Legal Issues of the Autonomous Vehicle/IoT Ecosystem," New York Law Journal, December 13, 2019
  • Co-author, "Autonomous Vehicles: "It's all about you!" The integration of biometrics into autonomous vehicles," Norton Rose Fulbright - Autonomous Vehicles White Paper, Volume 4, July 2019
  • Co-author, "Biometrics: Is It Always About You?" The Journal of Robotics, Artificial Intelligence & Law, March-April 2019
  • Member, American Association for the Advancement of Science (AAAS)
  • Member, American Intellectual Property Law Association (AIPLA)
  • Member, National Asian Pacific American Bar Association (NAPABA)
  • Member, New York City Bar Association